Literature DB >> 32797237

Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy?

Sarah C J Jorgensen1, Lisa Burry1,2, Christopher L Y Tse2, Linda D Dresser2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 32797237      PMCID： PMC7454398          DOI： 10.1093/cid/ciaa1208

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  1 in total

1.  Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials.

Authors:  Dimitrios Patoulias; Michael Doumas; Christodoulos Papadopoulos; Asterios Karagiannis
Journal:  Clin Rheumatol       Date:  2021-08-24       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.